Ceftolozane/Tazobactam Dose Selection for Pediatric Patients (birth to < 18 years)

被引：0
|
作者：
Larson, Kajal B. [1 ]
Patel, Yogesh T. [2 ]
Willavize, Susan [2 ]
Rizk, Matthew L. [1 ]
Yu, Brian [1 ]
Johnson, Matthew G. [1 ]
Rhee, Elizabeth G. [1 ]
Caro, Luzelena [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] Cognigen Corp, Buffalo, NY USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2017年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
T-078
引用
收藏
页码：S87 / S87
页数：1
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY OF SOFOSBUVIR/VELPATASVIR (SOF/VEL) IN PEDIATRIC PATIENTS 6 TO < 18 YEARS OLD WITH CHRONIC HEPATITIS C (CHC) INFECTION
    Jonas, Maureen
    Romero, Rene
    Sokal, Etienne
    Rosenthal, Philip
    Verucchi, Gabriella
    Lin, Chuan-Hao
    Wen, Jessica
    Narkewicz, Michael
    Bansal, Sanjay
    Shao, Jiang
    Hsueh, Sean
    Gaggar, Anuj
    Kersey, Kathryn
    Chan, Carol Yee Kwan
    Gonzalez-Peralta, Regino
    Leung, Daniel
    Balistreri, William
    Murray, Karen
    Schwarz, Kathleen
    GUT, 2020, 69 : A74 - A74
  • [22] Model-informed dose optimization for prophylactic piperacillin-tazobactam in perioperative pediatric critically ill patients
    Tan, Wen Rui
    Irie, Kei
    Mcintire, Carter
    Torres, Julie Luna
    Jones, Rhonda
    Gibson, Abigayle
    Mizuno, Tomoyuki
    Girdwood, Sonya Tang
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2025, 69 (03)
  • [23] Avelumab Dose Selection for Clinical Studies in Pediatric Patients with Solid Tumors
    Yulia Vugmeyster
    Ana-Marija Grisic
    Brigitte Brockhaus
    Peter Rueckert
    Mary Ruisi
    Haiqing Dai
    Akash Khandelwal
    Clinical Pharmacokinetics, 2022, 61 : 985 - 995
  • [24] Avelumab Dose Selection for Clinical Studies in Pediatric Patients with Solid Tumors
    Vugmeyster, Yulia
    Grisic, Ana-Marija
    Brockhaus, Brigitte
    Rueckert, Peter
    Ruisi, Mary
    Dai, Haiqing
    Khandelwal, Akash
    CLINICAL PHARMACOKINETICS, 2022, 61 (07) : 985 - 995
  • [25] Pharmacokinetics and Optimal Dose Selection of Cefazolin for Surgical Prophylaxis of Pediatric Patients
    Schmitz, Michael L.
    Rubino, Christopher M.
    Onufrak, Nikolas J.
    Martinez, Diana Valencia
    Licursi, Diane
    Karpf, Angela
    Cetnarowski, Wes
    JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (05): : 666 - 676
  • [26] A 6-year retrospective review of pediatric firearm injuries: Do patients < 14 years of age differ from those 15-18 years of age?
    Hendry, Phyllis L.
    Suen, Andrea
    Kalynych, Colleen J.
    Lott, Michelle
    Paul, Julia
    Smotherman, Carmen
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 77 : S41 - S45
  • [27] REDUCING CERVICAL SPINE IMAGING IN PEDIATRIC TRAUMA PATIENTS<11 YEARS OF AGE
    Zeretzke, C.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2016, 64 (02) : 545 - 545
  • [28] Population Pharmacokinetic Modeling of Pantoprazole in Pediatric Patients From Birth to 16 Years
    Knebel, W.
    Tammara, B.
    Udata, C.
    Comer, G.
    Gastonguay, M. R.
    Meng, X.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (03): : 333 - 345
  • [29] CLINICAL FEATURES IN CHILDREN AND ADOLESCENTS AGED < 18 YEARS WITH SEVERE COVID IN A MEXICAN PEDIATRIC CRITICAL CARE UNIT
    Flores, M. Fonseca
    Sarlat, M. Ibarra
    Hernandez, C. D. Garcia
    PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [30] Feasibility of Low Dose 18FDG PET in Pediatric Oncology Patients
    Zhang, J.
    Binzel, K.
    Hall, N. C.
    Natwa, M.
    Knopp, M. I.
    Knopp, M. V.
    MEDICAL PHYSICS, 2016, 43 (06) : 3679 - 3679
12345